Homologous recombination deficiency testing implementation in the routine clinical setting: real-life experience and lessons learned
{{output}}
Background: Homologous recombination deficiency (HRD) is a critical biomarker for predicting response to poly (ADP-ribose) polymerase (PARP) inhibitors in high-grade serous ovarian cancer (HGSOC). Hence, genomic scar-based HRD te... ...
